1. PI3K/Akt/mTOR Autophagy
  2. mTOR Autophagy
  3. mTORC1-IN-3

mTORC1-IN-3 是一种强效且具有选择性的 mTORC1 抑制剂,其 IC50 值为 26.38 μM。mTORC1-IN-3 可选择性地抑制 mTORC1 底物的磷酸化,而不会影响 mTORC2 底物的磷酸化。mTORC1-IN-3 能够减少细胞内脂质蓄积并诱导自噬 (autophagy)。mTORC1-IN-3 可用于癌症、免疫学、代谢性疾病和神经系统疾病的研究,如糖尿病和阿尔茨海默病。

MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

mTORC1-IN-3

mTORC1-IN-3 Chemical Structure

1.  客户无需承担相应的运输费用。

2.  同一机构(单位)同一产品试用装仅限申领一次,同一机构(单位)一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户

规格 是否有货
50 mg   询价  
100 mg   询价  
250 mg   询价  

* Please select Quantity before adding items.

Customer Review

查看 mTOR 亚型特异性产品:

  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

生物活性

mTORC1-IN-3 is a potent and selective mTORC1 inhibitor with an IC50 of 26.38 μM . mTORC1-IN-3 selectively inhibits the phosphorylation of mTORC1 substrates and does not without affect the phosphorylation of mTORC2 substrate. mTORC1-IN-3 can reduce cellular lipid accumulation and induce autophagy. mTORC1-IN-3 can be used for the researches of cancer, immunology, metabolic and neurological disease, such as diabetes and Alzheimer’s disease[1].

IC50 & Target[1]

mTORC1

26.38 μM (IC50)

体外研究
(In Vitro)

mTORC1-IN-3 (Compound TCG3) (10 μM, 2 h) 可选择性抑制 HepG2 细胞和小鼠原代肝细胞中 mTORC1 底物 p-p70S6K (Thr389)、p-S6 (Ser235/236) 和 p-4E-BP1 (Thr37/46) 的磷酸化,而不影响 mTORC2 底物 p-Akt(Ser473) 的磷酸化[1]
mTORC1-IN-3 (10 μM, 24 h) 可抑制 AMPK 介导的 ULK1 (Ser757) 磷酸化,从而减少 ULK1 的激活,并在 HepG2 细胞中诱导自噬的早期阶段[1]
mTORC1-IN-3 (10 μM, 24 h) 可减少脂肪酸诱导的 HepG2 细胞中脂滴的积累[1]
mTORC1-IN-3 (1-30 μM, 24 h) 在 HepG2 细胞中显示出低细胞毒性[1]
mTORC1-IN-3 (10 μM, 24 h) 可持续抑制 HEK293T、JURKAT 和 786-O 细胞中 mTORC1 底物的磷酸化[1]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Western Blot Analysis[1]

Cell Line: HepG2 cells and mouse primary hepatocytes
Concentration: 10 μM
Incubation Time: 2 h
Result: Reduced the levels of p-p70S6K (Thr389), p-S6 (Ser235/236) and p-4E-BP1 (Thr37/46).
体内研究
(In Vivo)

mTORC1-IN-3 (Compound TCG3) (15 mg/kg,腹腔注射,胰岛素注射前 30 分钟) 可逆转 C57BL/6 小鼠中胰岛素介导的低血糖[1]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: C57BL/6 mice (male, 6-8 weeks)[1]
Dosage: 15 mg/kg
Administration: Intraperitoneally injection, 30 mins before insulin injection
Result: Reversed insulin-mediated hypoglycemiaand increased plasma glucose levels.
Inhibited insulin-induced phosphorylation of mTORC1 substrates p-S6 (Ser235/236) and p-4E-BP1 (Thr37/46) in liver.
Showed a 40% reduction in p-S6 positive area.
Showed no abnormalities or hepatocyte damage in liver.
分子量

909.84

Formula

C41H43F4N11O9

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

纯度 & 产品资料
参考文献
  • 摩尔计算器

  • 稀释计算器

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称:

 

* 需求量:

* 客户姓名:

 

* Email:

* 电话:

 

* 公司或机构名称:

   留言给我们:

Bulk Inquiry

Inquiry Information

产品名称:
mTORC1-IN-3
目录号:
HY-178192
需求量: